T cell immunity to B. anthracis
T cell immunity to B. anthracis
批准号:
6759560
负责人:
Zheng W Chen
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2004-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): B. anthracis has long been considered a potential biological warfare agent. One of the biodefense research priorities is to develop improved anthrax vaccines. Cell-mediated immune responses may play an important role in vaccine-induced protection against anthrax. Vgamma2Vdelta2 T cells exist only in primates and constitute 60-95% of total human gammadeltaT cell population in the blood. We have recently demonstrated that phosphoantigen-specific Vgamma2Vdelta2 T cells can contribute to adaptive immunity to fatal mycobacterial infection. We have also shown that B. anthracis, like mycobacteria, carries a novel gene encoding GcpE protein that mediates production of phosphoantigen recognized by Vgamma2Vdelta2 T cells. B. anthracis infection of monkeys could prime phosphoantigen-specific Vgamma2Vdelta2 T cells, and result in cross-reactive memory-type responses of these gammadeltaT cells after subsequent infection with phosphoantigen-producing mycobacteria. Since the current anthrax vaccine contains only protein antigens of B. anthracis, phosphoantigen may provide an important addition to anthrax vaccine regimens. We hypothesize that Vgamma2Vdelta2 T cells contribute to both innate and adaptive immune protection against B. anthracis infection. Since peptide-specific CD4 and CD8 T cells may play a role in immunity to anthrax, we further hypothesize that a combined vaccine targeting both phosphoantigen-specific Vgamma2Vdelta2 T cells and peptide-specific CD4 and CD8 T cells are more efficient for immunization and vaccine-induced protection against anthrax. In this R21 application, we will
I. Determine vaccine-elicited immune responses of Vgamma2Vdelta2 T cells, and CD4 and CD8 T cells in macaques immunized with a combined vaccine comprised of phosphoantigen and protective antigen (PA) of B. anthracis.
II. Determine if combined phosphoantigen and PA immunization of Vgamma2Vdelta2 T cells, CD4 and CD8 T cells can confer protective immunity to inhalation anthrax.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
-
批准号:8670046
-
项目类别:
-
资助金额:$55.62万
-
财政年份:2013
-
负责人:Zheng W Chen
-
依托单位:
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
-
批准号:8501805
-
项目类别:
-
资助金额:$55.62万
-
财政年份:2013
-
负责人:Zheng W Chen
-
依托单位:
Immune function and mechanism of Tim3 expression and Tim3+ T cells in TB & HIV+TB
-
批准号:8892993
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:Zheng W Chen
-
依托单位:
Immune function and mechanism of Tim3 expression and Tim3+ T cells in TB & HIV+TB
-
批准号:8721335
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:Zheng W Chen
-
依托单位:
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
-
批准号:8846156
-
项目类别:
-
资助金额:$55.5万
-
财政年份:2013
-
负责人:Zheng W Chen
-
依托单位:
6th International gamma delta T-cell conference
-
批准号:8652003
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2013
-
负责人:Zheng W Chen
-
依托单位:
Immune function and mechanism of Tim3 expression and Tim3+ T cells in TB & HIV+TB
-
批准号:8546669
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:Zheng W Chen
-
依托单位:
GAMMA DELTA T CELLS AND TUBERCULOSIS
-
批准号:7958662
-
项目类别:
-
资助金额:$6.01万
-
财政年份:2009
-
负责人:Zheng W Chen
-
依托单位:
GAMMA DELTA T CELLS AND TUBERCULOSIS
-
批准号:7716314
-
项目类别:
-
资助金额:$2.36万
-
财政年份:2008
-
负责人:Zheng W Chen
-
依托单位:
Immunotherapeutics and vaccines against anthrax, plague and tularemia
-
批准号:7653679
-
项目类别:
-
资助金额:$94.1万
-
财政年份:2006
-
负责人:Zheng W Chen
-
依托单位:
Immunotherapeutics and vaccines against anthrax, plague and tularemia
-
批准号:7919995
-
项目类别:
-
资助金额:$95.66万
-
财政年份:2006
-
负责人:Zheng W Chen
-
依托单位:
Immunotherapeutics and vaccines against anthrax, plague and tularemia
-
批准号:7251890
-
项目类别:
-
资助金额:$90.97万
-
财政年份:2006
-
负责人:Zheng W Chen
-
依托单位:
Immunotherapeutics and vaccines against anthrax, plague and tularemia
-
批准号:7134833
-
项目类别:
-
资助金额:$94.03万
-
财政年份:2006
-
负责人:Zheng W Chen
-
依托单位:
Immunotherapeutics and vaccines against anthrax, plague and tularemia
-
批准号:7468390
-
项目类别:
-
资助金额:$91.64万
-
财政年份:2006
-
负责人:Zheng W Chen
-
依托单位:
T cell immunity to B. anthracis
-
批准号:6953764
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2004
-
负责人:Zheng W Chen
-
依托单位:
T cell immunity to B. anthracis
-
批准号:7003544
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2004
-
负责人:Zheng W Chen
-
依托单位:
IMMUNOPATHOGENESIS OF MYCOBACTERIUM & SIV COINFECTION IN MACAQUES
-
批准号:6591336
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:Zheng W Chen
-
依托单位:
RESTORATION OF TCR REPERTOIRE AFTER DEPLETION
-
批准号:6666379
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2002
-
负责人:Zheng W Chen
-
依托单位:
RESTORATION OF TCR REPERTOIRE AFTER DEPLETION
-
批准号:6655229
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2002
-
负责人:Zheng W Chen
-
依托单位:
RESTORATION OF TCR REPERTOIRE AFTER DEPLETION
-
批准号:6506275
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2001
-
负责人:Zheng W Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于多组学技术研究肠道微生物在猕猴(Macaca mulatta)衰老过程中的作用机制
-
批准号:32370450
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:范振鑫
-
依托单位:
太行山猕猴(Macaca mulatta tcheliensis)雌性的配偶选择
-
批准号:32070446
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路纪琪
-
依托单位:
猕猴(Macaca mulatta)衰老过程中凝血功能变化规律及基因表达调控机制研究
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2020
-
负责人:范振鑫
-
依托单位:
猕猴(Macaca mulatta)衰老过程中凝血功能变化规律及基因表达调控机制研究
-
批准号:32070413
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:范振鑫
-
依托单位:
太行山猕猴(Macaca mulatta tcheliensis)雌性的配偶选择
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2020
-
负责人:路纪琪
-
依托单位:
猕猴(Macaca mulatta)亚种及其近缘种比较基因组学研究
-
批准号:31471989
-
项目类别:面上项目
-
资助金额:85.0万元
-
批准年份:2014
-
负责人:刘志瑾
-
依托单位: